All In MedTech

Device Trial Radar · NCT03289000

A Retrospective Study to Evaluate the ConforMIS iTotal® Posterior Stabilized (PS) Knee Replacement System

Last checked: Nov 19, 2026Latest source record: Oct 25, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

93

Actual

Start

Apr 24, 2017

Primary completion

Aug 4, 2017

Study completion Dec 31, 2017

Sponsor

Lead sponsor
Restor3DNot on our public-company list
Sponsor type
Industry
First posted
Sep 20, 2017

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study is a retrospective, multi-center study, with one single remote follow up contact. This study will include a minimum of 80 patients and a maximum 100 patients who have been treated with the ConforMIS iTotal PS knee product.

Conditions

  • Osteo Arthritis Knee

Interventions

  • iTotal Posterior Stabilized (PS) Knee Replacement SystemDevice

    Patient-specific posterior stabilized total knee replacement and patient specific surgical jigs

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Demographics and Medical HistoryTime frame: 1 year
  2. Pre and Post Operative Range of MotionTime frame: 1 year

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • Tennessee Orthopaedic Alliance

    Nashville, Tennessee

  • Scott Orthopedic Center

    Huntington, West Virginia

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.